Xiidra

Lifitegrast, sold under the brand name Xiidra (/zadr/[1]), is a medication for the treatment of signs and symptoms of dry eye, a syndrome called keratoconjunctivitis sicca. Lifitegrast reduces inflammation by inhibiting inflammatory cell binding.[2] It is often used in conjunction with ciclosporin (Ikervis or Restasis) for dry eye treatment including meibomian gland dysfunction and inflammatory dry eye. Contents 1 Adverse effects 2 Pharmacology 2.1 Mechanism... [wikipedia]